MedTrace Logo

ATHN 9: Severe VWD Natural History Study

NCT03853486 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2025-03-12

No results posted yet for this study

Summary

ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.

Conditions

  • Von Willebrand Diseases

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • American Thrombosis and Hemostasis Network

    lead NETWORK

Principal Investigators

  • Robert Sidonio, MD · Emory University / Children's Healthcare of Atlanta

  • Angela Weyand, MD · University of Michigan Hemophilia and Coagulation Disorders

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2025-12-31
Completion
2026-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853486 on ClinicalTrials.gov